News
DNOW Inc. (NYSE: DNOW) ("DNOW" or "the Company") and MRC Global Inc. (NYSE: MRC) ("MRC Global") today announced that they have entered into a definitive merger agreement pursuant to which DNOW will ...
Universities and their trade associations have already sued the NIH, DOE and NSF over these plans, arguing that capping indirect costs would hurt research production and compromise global ...
With indirect tax being a transaction-based tax that generates large volumes of data, the use of AI is crucial. The implementation of e-invoicing, although a direct tax initiative, represents a ...
A six-step cost-to-serve (CTS) model should be used by chief supply chain officers (CSCOs) as a means to accurately reflect supply chain costs and profitability, according to Gartner. This model helps ...
The strategic importance of indirect procurement often remains underappreciated despite its considerable impact on organizational efficiency and financial performance. Effective management of indirect ...
According to Milk Road, a new real-time ETH gas fee tracker has been launched to help users avoid overpaying on Ethereum transactions. This tool provides up-to-the-minute gas fee data, enabling ...
Cornell Sues DOE for ‘Unlawful’ Cuts to Indirect Costs for Research Grants By Matthew Kiviat Apr 14, 2025 2:32 pm · Updated Apr 14, 2025 2:32 pm Reading time: about 3 minutes ...
However, days before the DOE announced its plan to cap indirect costs, a coalition of 10 academic and research organizations, including COGR, the Association of American Universities and the ...
According to Compounding Quality (@QCompounding), trading fees, taxes, and other transaction costs significantly reduce investment returns, highlighting the importance of minimizing expenses to ...
Harvard’s indirect cost rate — the percent of federal funding that covers administrative costs of research — is currently 69 percent, the largest of any Ivy League school.
Also, while related-party transactions exceeding 10% of turnover, total assets, or net worth require shareholder approval under the Companies Act, 2013, Sebi's new guidelines set the standard at 2 ...
Stoke Therapeutics CEO Edward Kaye stated: “With Biogen’s deep experience in neurology and track record of success in commercialising high-value disease-modifying medicines for rare genetic diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results